Experience

VMS BioMarketing
• United States
• Advertising Services
• 100 - 200 Employee
• National Clinical Manager

  • Feb 2023 - Present


Genentech

• United States
• Biotechnology Research
• 700 & Above Employee

• Rheumatology Clinical Education Manager

  • Aug 2017 - Oct 2020

  Led clinical team that was responsible for HCP education and support of 2 infused biologics for the treatment of rheumatoid arthritis, rare disease, and vasculitis. Led a pilot focused on disease state education for patients. Clinical team responsibilities included KOL management and speaker training. Collaborated with marketing, access, and customer service to develop a project and materials for a rare disease. This team was recognized with an innovation award.

• Regional Manager

  • Jul 2017 - Sep 2020



PDI, Inc.

• Pharmaceutical Manufacturing
• 100 - 200 Employee

• National Clinical Program Manager

  • Feb 2017 - Jul 2017

  Recruited to lead a national team of 13 specialists at Sunovion serving in a hybrid clinical/sales role to support the launch of a COPD inhaler. Partnered with the sales team to drive utilization among primary care and pulmonologists across the United States. Recruited to lead a national team of 13 specialists at Sunovion serving in a hybrid clinical/sales role to support the launch of a COPD inhaler. Partnered with the sales team to drive utilization among primary care and pulmonologists across the United States.

• Regional Manager

  • Mar 2014 - Nov 2016

  In partnership with Astra Zeneca; recruited a team in Florida, Georgia, Mississippi, and Alabama to educate patients about the use of a once weekly injectable GLP1 for the treatment of diabetes. Responsibilities include coaching to achieve metrics, building territory plans, and working closely with AZ leadership and managed care team to achieve mutual goals. The Southeast team met or exceeded quarterly goals throughout the entire contract. In partnership with Astra Zeneca; recruited a team in Florida, Georgia, Mississippi, and Alabama to educate patients about the use of a once weekly injectable GLP1 for the treatment of diabetes. Responsibilities include coaching to achieve metrics, building territory plans, and working closely with AZ leadership and managed care team to achieve mutual goals. The Southeast team met or exceeded quarterly goals throughout the entire contract.



inVentiv Health Commercial

• United States
• Pharmaceutical Manufacturing
• 400 - 500 Employee

• Hospital District Manager

  • May 2013 - Mar 2014

  In partnership with Astra Zeneca, built and led a hybrid clinical team supporting the sales of an oral anti-platelet. The Miami team was instrumental in the success of adoption of the oral platelet in the transitional care space. In partnership with Astra Zeneca, built and led a hybrid clinical team supporting the sales of an oral anti-platelet. The Miami team was instrumental in the success of adoption of the oral platelet in the transitional care space.



Amylin Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 400 - 500 Employee

• District Sales Manager

  • Nov 2006 - May 2012

  Successfully recruited and led sales teams in the West and Central regions of the US. Teams were responsible for the promotion of 3 first in class injectable products for diabetes. Worked strategically with managed care team, responsible for KOL and speaker development in the West and Central regions, and served as West region liaison to the marketing team. Regional district award based on sales attainment; 8 team members achieved President's Club award.

• Senior Territory Manager Northwest Arkansas

  • May 2005 - Nov 2006

  Successfully launched and promoted 2 first in class diabetes products. Byetta and Symlin. Customer base included endocrinologists and primary care physicians.



Eisai US

• Pharmaceutical Manufacturing
• 700 & Above Employee

• Neurology Sales Specialist

  • 2004 - 2005

  Launched and promoted an anticonvulsant for partial complex seizure disorder to neurologists. Also responsible for the promotion of a cholinesterase inhibitor for the treatment of Alzheimers Disease. Launched and promoted an anticonvulsant for partial complex seizure disorder to neurologists. Also responsible for the promotion of a cholinesterase inhibitor for the treatment of Alzheimers Disease.



Roche Pharmaceuticals

• Brazil
• Personal Care Product Manufacturing
• 1 - 100 Employee

• Medical Representative

  • 1996 - 2004

  President's Club Achievement in 2003, Special Achievement Award in 1997, 1998, 2001, and 2003. Developed and maintained customer relationships and successfully launched and promoted several pharmaceutical products which included: an injectable antibiotic; a lipase inhibitor used for weight loss; a neuraminidase inhibitor used to treat influenza; an alpha beta blocker used for congestive heart failure; and a platelet aggregation inhibitor used for stroke. Instrumental in establishing IV… Show more President's Club Achievement in 2003, Special Achievement Award in 1997, 1998, 2001, and 2003. Developed and maintained customer relationships and successfully launched and promoted several pharmaceutical products which included: an injectable antibiotic; a lipase inhibitor used for weight loss; a neuraminidase inhibitor used to treat influenza; an alpha beta blocker used for congestive heart failure; and a platelet aggregation inhibitor used for stroke. Instrumental in establishing IV infusion centers and congestive heart failure clinics. Show less President's Club Achievement in 2003, Special Achievement Award in 1997, 1998, 2001, and 2003. Developed and maintained customer relationships and successfully launched and promoted several pharmaceutical products which included: an injectable antibiotic; a lipase inhibitor used for weight loss; a neuraminidase inhibitor used to treat influenza; an alpha beta blocker used for congestive heart failure; and a platelet aggregation inhibitor used for stroke. Instrumental in establishing IV… Show more President's Club Achievement in 2003, Special Achievement Award in 1997, 1998, 2001, and 2003. Developed and maintained customer relationships and successfully launched and promoted several pharmaceutical products which included: an injectable antibiotic; a lipase inhibitor used for weight loss; a neuraminidase inhibitor used to treat influenza; an alpha beta blocker used for congestive heart failure; and a platelet aggregation inhibitor used for stroke. Instrumental in establishing IV infusion centers and congestive heart failure clinics. Show less